Get the Stockscreener App
5.76
2.86%
0.16
After Hours:
5.76
Profound Medical Corp stock is traded at $5.76, with a volume of 265.31K.
It is up +2.86% in the last 24 hours and down -15.42% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
See More
Previous Close:
$5.60
Open:
$5.705
24h Volume:
265.31K
Relative Volume:
2.32
Market Cap:
$210.47M
Revenue:
$18.81M
Net Income/Loss:
$-38.90M
P/E Ratio:
-4.6169
EPS:
-1.2476
Net Cash Flow:
$-38.83M
1W Performance:
-1.71%
1M Performance:
-15.42%
6M Performance:
-1.03%
1Y Performance:
+12.50%
1-Day Range:
$5.61
$5.8599
1-Week Range:
$5.60
$6.40
52-Week Range:
$4.80
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.76 | 210.47M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Is Profound Medical (TSX:PRN) A Canadian Medical Device Stock? - Kalkine Media
Profound Medical Stock Slips as Selling Pressure Returns: Can TSX:PRN Stabilize Despite Improving Commercial Momentum? - kalkine.ca
(PROF) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Profound Medical Corp. Share PricePRN, RNS News, Articles, Quotes, & Charts (TSE:PRN) - Proactive financial news
What Is Behind Profound Medical (TSX:PRN) President’s Stock Activity? - Kalkine Media
President of Profound Medical Richard Fabian Buys More Stock - simplywall.st
Profound Medical Corp. (TSX:PRN) Gains Momentum as Innovative Medical Technology Platform and TULSA-PRO Expansion Drive Investor Optimism - kalkine.ca
WHY Power Metallic Mines (TSXV:PNPN), Millennial Potash (TSXV:MLP), Real Matters (TSX:REAL), High Tide (TSXV:HITI) and Profound Medical (TSX:PRN) Could Put the TSX SmallCap Watchlist in Focus in September 2026 - kalkine.ca
Profound Medical (TSX:PRN) Slides 11.92% as Bearish Pressure Builds: Can TULSA-PRO Momentum Offset Near-Term Weakness? - kalkine.ca
Profound Medical Stock Drops 11.92% as Investor Caution Builds Around Growth, Execution and Valuation - kalkine.ca
Why Profound Medical Corp stock plummeted yesterday - Wealth Awesome
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
What's Going On With Profound Medical Corp Stock Monday? - Wealth Awesome
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch - Yahoo Finance
Profound Medical Corp. (PROF) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Profound Medical to Present at BIG10 Growth Conference - TipRanks
Profound Medical (NASDAQ: PROF) plans one-on-one investor talks at BIG10 conference - Stock Titan
PROF Q2 2026 Earnings: Narrow Loss Beat Fails to Halt Stock DeclineEPS Consistency Score - dars.gov.et
Profound Medical Corp. (PROF) Peer Comparison – Compare with Others - Value Research
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference - investingnews.com
Profound Medical Corp. to Present at Lake Street Capital Markets BIG10 Conference on September 10 - kalkine.ca
Profound Medical Names Richard Fabian as New President - TipRanks
Profound Medical names Richard R. Fabian as President; Mathieu Burtnyk becomes CTO - TradingView
New Profound Medical (PROF) president set for $550,000 salary plus stock awards - Stock Titan
(PROF) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Profound Medical names Richard Fabian as president By Investing.com - Investing.com Australia
Profound Medical Appoints Richard Fabian as President - marketscreener.com
Profound Medical Taps Industry Veteran Richard Fabian as President in Leadership Realignment - tipranks.com
Profound Medical Names Industry Veteran Richard Fabian as President in Leadership Realignment - TipRanks
Profound Medical Appoints Richard Fabian President - marketscreener.com
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President - GlobeNewswire
Profound Medical Corp. (PROF) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Profound Medical Stock Falls 2.63%: Can TSX:PRN Overcome Commercialization Challenges and Healthcare Technology Risks? - kalkine.ca
Quipt Home Medical Corp (QIPT) Peer Comparison – Compare with Others - Value Research
Profound Medical Corp. (TSX:PRN) Gains Momentum as TULSA-PRO Innovation Strengthens Healthcare Technology Outlook - kalkine.ca
Profound Medical Corp. Stock Surges 4.46% as Trading Activity Spikes and Market Attention Builds - kalkine.ca
Profound Medical (TSX:PRN) Stock Rises 4.35% as TULSA Growth, Reimbursement and New MRI Software Drive Investor Attention - kalkine.ca
Profound (PROF) Results Versus Estimates: Reported EPS Tops Expectations in the Current Update; Post-Earnings: The Share Price Adds 2.11%Revenue Surprise History - vinanet.vn
Profound (PROF) Close: Posts a 2.11% Gain to $6.79 at the Close; Level Watch: the $6.45 to $7.13 Range Remains in Focus in the Latest SessionShakeout Pattern - dars.gov.et
Why Did Profound Medical Corp. (TSX:PRN) Stock Suffer a 6.67% Drop on 20 August 2026? - kalkine.ca
Profound Medical Slides Despite New MRI Technology and a Narrower Loss — Why Aren't Investors Convinced? - kalkine.ca
Profound (PROF) Earnings Report: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Investor Response: The Stock Ends Down 6.07% in the Available RecordRevenue Warning Signal - vinanet.vn
Profound Medical (PROF) Q2 2026 Earnings Call Transcript - AOL.ca
Why Did Profound Medical Corp. (TSX:PRN) Surge 6.09% on 18 August 2026? - kalkine.ca
Why Profound Medical Corp stock surged yesterday - Wealth Awesome
Profound Medical Stock: Record Orders Meet a CFO Shake-Up - kalkine.ca
Profound Medical (TSX:PRN) Captures Focus Amid Developing Healthcare Story - Kalkine Media
Why Profound Medical Corp stock is skyrocketing today - Wealth Awesome
Profound Medical (TSX:PRN): Could The Market Be Seeing More Potential Ahead? - Kalkine Media
Profound Medical Names Matthew Sobczyk as Interim CFO Following Rashed Dewan’s Departure - Kalkine Media
Profound Medical (TSE:PRN) Insider Thomas Michael Tamberrino Buys 3,755 Shares of Stock - MarketBeat
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):